Literature DB >> 29411193

[Paraneoplastic cerebellar degeneration (PCD) - an interdisciplinary challenge in neurology, oncology and palliative care].

Sabine Burger1, Stefan Lorenzl2.   

Abstract

Paraneoplastic neurological syndromes describe a very heterogeneous group of neurological disorders. Paraneoplastic cerebellar degeneration is frequently associated with gynecological tumors, lung cancer and Hodgkin lymphoma. The following case report shows the typical course of this disease as well as the diagnostic and therapeutic challenges. Furthermore the importance of interdisciplinary cooperation between neurology, oncology and palliative care for prognosis and symptom stabilization is highlighted.

Entities:  

Keywords:  Course of disease; Interdisciplinary challenge; Paraneoplastic cerebellar degeneration; Tumor

Mesh：

Year:  2018        PMID： 29411193     DOI： 10.1007/s10354-018-0624-4

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  18 in total

1.  Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice.

Authors:  Jesús Planagumà; Frank Leypoldt; Francesco Mannara; Javier Gutiérrez-Cuesta; Elena Martín-García; Esther Aguilar; Maarten J Titulaer; Mar Petit-Pedrol; Ankit Jain; Rita Balice-Gordon; Melike Lakadamyali; Francesc Graus; Rafael Maldonado; Josep Dalmau
Journal:  Brain       Date:  2014-11-11       Impact factor: 13.501

2.  Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer.

Authors:  José Baselga; Mario Campone; Martine Piccart; Howard A Burris; Hope S Rugo; Tarek Sahmoud; Shinzaburo Noguchi; Michael Gnant; Kathleen I Pritchard; Fabienne Lebrun; J Thaddeus Beck; Yoshinori Ito; Denise Yardley; Ines Deleu; Alejandra Perez; Thomas Bachelot; Luc Vittori; Zhiying Xu; Pabak Mukhopadhyay; David Lebwohl; Gabriel N Hortobagyi
Journal:  N Engl J Med       Date:  2011-12-07       Impact factor: 91.245

3.  Gynaecology meets neurology: paraneoplastic cerebellar degeneration.

Authors:  Russell Land; Jonathan Carter; Roger Houghton; Ken Atkinson; Christopher Dalrymple
Journal:  Aust N Z J Obstet Gynaecol       Date:  2005-02       Impact factor: 2.100

4.  Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.

Authors:  Yudai Tanaka; Nao Suzuki; Masaki Takao; Akiko Ichikawa; Nobuyuki Susumu; Daisuke Aoki
Journal:  Gynecol Oncol       Date:  2005-08-29       Impact factor: 5.482

5.  Spectrum of paraneoplastic disease associated with lymphoma.

Authors:  C Briani; R Vitaliani; W Grisold; J Honnorat; F Graus; J C Antoine; G Bertolini; B Giometto
Journal:  Neurology       Date:  2011-02-22       Impact factor: 9.910

6.  Imbalance in circulating T lymphocyte subsets contributes to Hu antibody-associated paraneoplastic neurological syndromes.

Authors:  Lina Zhang; Weidong Qian; Qiming Chen; Liang Yin; Baiqing Li; Hongtao Wang
Journal:  Cell Immunol       Date:  2014-07-14       Impact factor: 4.868

Review 7.  Managing paraneoplastic neurological disorders.

Authors:  Janet W de Beukelaar; Peter A Sillevis Smitt
Journal:  Oncologist       Date:  2006-03

8.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Authors:  Setareh Shams'ili; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Herbert Hooijkaas; Bronno van der Holt; Charles Vecht; Peter Sillevis Smitt
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

Review 9.  Consensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.

Authors:  Hiroshi Mitoma; Keya Adhikari; Daniel Aeschlimann; Partha Chattopadhyay; Marios Hadjivassiliou; Christiane S Hampe; Jérôme Honnorat; Bastien Joubert; Shinji Kakei; Jongho Lee; Mario Manto; Akiko Matsunaga; Hidehiro Mizusawa; Kazunori Nanri; Priya Shanmugarajah; Makoto Yoneda; Nobuhiro Yuki
Journal:  Cerebellum       Date:  2016-04       Impact factor: 3.847

Review 10.  Immunopathogenesis of paraneoplastic neurological syndromes associated with anti-Hu antibodies: A beneficial antitumor immune response going awry.

Authors:  Béatrice Sl Pignolet; Christina Mt Gebauer; Roland S Liblau
Journal:  Oncoimmunology       Date:  2013-12-10       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.